# HedgePath Pharmaceuticals, Inc. — Form D

HedgePath Pharmaceuticals, Inc. of TAMPA, FL, a company, filed a Form D exempt-offering notice with the SEC on 2016-04-22. The offering totals $5.5M, of which $600K was reported sold. Industry: Pharmaceuticals.

## Offering

- Filed: 2016-04-22
- Form: D
- Accession: 0001465818-16-000103
- Industry: Pharmaceuticals
- Exemptions: 06c
- Total offering: $5.5M
- Amount sold: $600K
- Remaining: $4.9M
- Investors: 3
- Date of first sale: 2016-04-11
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-261874

## Issuer

- Name: HedgePath Pharmaceuticals, Inc.
- CIK: 0001042418
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 324 SOUTH HYDE PARK AVENUE, TAMPA, FL, 33606
- Phone: (813) 864-2559

## Officers, directors & promoters (8)

| Name | Role | Location |
| --- | --- | --- |
| Stefan J Cross | Director | Tampa, FL |
| Frank E O'Donnell, Jr., MD | Director | Tampa, FL |
| R. Dana Ono, MD | Director | Tampa, FL |
| Samuel P Sears, Jr. | Director | Tampa, FL |
| W. Mark Watson, CPA | Director | Tampa, FL |
| Garrison J Hasara, CPA | Executive Officer | Tampa, FL |
| Frank E O'Donnell, Jr., MD | Executive Officer | Tampa, FL |
| Nicholas J Virca | Executive Officer | Tampa, FL |

## More

- [CIK 1042418 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1042418&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0001465818-16-000103.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.